PYC Therapeutics Limited (PYCXF)

PYC Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 9, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	457	374	127	142	370	233
Market Cap Growth	36.18%	193.38%	-10.61%	-61.46%	58.81%	368.59%
Enterprise Value	427	358	117	113	329	215
PS Ratio	29.57	25.38	12.10	12.89	160.37	140.72
PB Ratio	13.27	6.91	6.73	5.14	9.14	11.17
P/TBV Ratio	14.35	7.33	8.14	5.92	10.19	14.28
EV/Sales Ratio	26.80	24.29	11.10	10.26	142.63	129.81
Debt / Equity Ratio	0.02	0.01	0.01	0.02	0.01	0.03
Asset Turnover	0.46	0.34	0.38	0.31	0.07	0.13
Quick Ratio	5.41	9.32	3.79	8.93	15.68	36.15
Current Ratio	5.46	9.40	3.79	8.95	15.71	36.23
Return on Equity (ROE)	-112.79%	-69.61%	-68.05%	-30.37%	-44.29%	-38.80%
Return on Assets (ROA)	-58.01%	-37.83%	-35.49%	-17.29%	-26.20%	-23.88%
Return on Capital (ROIC)	-71.07%	-43.79%	-41.90%	-18.64%	-27.38%	-24.49%
Earnings Yield	-6.52%	-6.74%	-11.91%	-6.71%	-3.60%	-2.02%
FCF Yield	-6.70%	-6.95%	-13.02%	-10.72%	-2.51%	-1.74%
Buyback Yield / Dilution	-25.01%	-22.59%	-0.93%	-2.89%	-12.58%	-17.18%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.